Comparison 13. DSG 150 µg / EE 30 µg versus GSD 75 µg / EE 30 µg.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Women without acne at cycle 6	2	1180	Peto Odds Ratio (Peto, Fixed, 95% CI)	1.17 [0.82, 1.66]
2 Women with mild acne at cycle 6	2	1180	Peto Odds Ratio (Peto, Fixed, 95% CI)	0.76 [0.52, 1.10]
3 Women with moderate or severe acne at cycle 6	2	1180	Peto Odds Ratio (Peto, Fixed, 95% CI)	1.78 [0.73, 4.32]
4 Women with mild or no acne at cycle 9	1	19	Peto Odds Ratio (Peto, Fixed, 95% CI)	5.05 [0.57, 44.42]
5 Women with improved acne score at cycle 9	1	19	Peto Odds Ratio (Peto, Fixed, 95% CI)	1.41 [0.08, 25.31]
6 Discontinuation due to side effects	2	1378	Peto Odds Ratio (Peto, Fixed, 95% CI)	0.61 [0.40, 0.93]